INR 9.64
(-2.03%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 150.94 Million | 2.51 Billion | -136.54 Million | -336.62 Million | -1.29 Billion | -419.95 Million |
Net Income | -38.22 Billion | -27.87 Billion | -9.8 Billion | -13.07 Billion | -15.31 Billion | -8.33 Billion |
Depreciation & Amortization | 61.86 Million | 62.47 Million | 63.9 Million | 70.07 Million | 68.84 Million | 62.45 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 7.72 Billion | 2.75 Billion | 212.26 Million | 826.23 Million | 1.12 Billion | 1.21 Billion |
Other non-cash items | 30.65 Billion | 27.56 Billion | 9.39 Billion | 11.84 Billion | 12.83 Billion | 6.64 Billion |
Investing Cash Flow | 131.04 Million | 40.72 Million | 583.42 Million | 677.12 Million | -217.81 Million | 837.76 Million |
Investments in PPE | -21.22 Million | -36.85 Million | -53.11 Million | -62.45 Million | -87.74 Million | 10.38 Million |
Acquisitions | - | 860 Thousand | - | 38.41 Million | 472 Thousand | 1.18 Billion |
Investment purchases | -65.43 Million | -605.48 Million | - | 84.34 Million | -426.5 Million | -436.42 Million |
Sales/Maturities of investments | - | - | 81.97 Million | 616.81 Million | - | 271.66 Million |
Other Investing Activities | 152.27 Million | 682.2 Million | 554.55 Million | -1000.00 | 295.96 Million | -188.05 Million |
Financing Cash Flow | -103.32 Million | -246.47 Million | -318.82 Million | -536.62 Million | 1.67 Billion | -202.74 Million |
Debt repayment | -77.09 Million | -98.82 Million | -126.78 Million | -174.36 Million | -363.29 Million | -829.15 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -25.58 Million | -147.65 Million | -192.04 Million | -362.25 Million | 2.03 Billion | 626.41 Million |
Accounts receivables | 258.24 Million | 142.4 Million | -280.26 Million | -340.06 Million | 4.12 Billion | 428.72 Million |
Accounts payables | 3.61 Billion | 1.2 Billion | 8.7 Billion | 4.77 Billion | -9.62 Billion | 10.47 Billion |
Inventory | -302.67 Million | 599.94 Million | 1.04 Million | -6.17 Million | 1.24 Billion | 264.09 Million |
Other working capital | 4.15 Billion | 814.15 Million | -8.21 Billion | -3.6 Billion | 5.37 Billion | -9.95 Billion |
Cash at beginning of period | 3 Billion | 700.22 Million | 572.17 Million | 768.3 Million | 605.73 Million | 390.66 Million |
Cash at end of period | 3.18 Billion | 3 Billion | 700.22 Million | 572.17 Million | 768.3 Million | 605.73 Million |
Capital Expenditure | -21.22 Million | -36.85 Million | -53.11 Million | -62.45 Million | -87.74 Million | 10.38 Million |
Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
Net cash flow / Change in cash | 178.66 Million | 2.3 Billion | 128.05 Million | -196.12 Million | 162.56 Million | 215.06 Million |
Free Cash Flow | 129.71 Million | 2.47 Billion | -189.65 Million | -399.07 Million | -1.37 Billion | -409.57 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -10.75 Billion | -14.42 Billion | -38.22 Billion | -6.65 Billion | -6.28 Billion | -5.89 Billion |
Depreciation & Amortization | - | - | 61.86 Million | 16.66 Million | 15.72 Million | 15 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 7.72 Billion | - | - | - |
Other non-cash items | 10.75 Billion | 14.42 Billion | 30.65 Billion | 6.65 Billion | 6.28 Billion | 5.89 Billion |
Investing Cash Flow | - | - | 131.04 Million | - | - | - |
Investments in PPE | - | - | -21.22 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -65.43 Million | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | -103.32 Million | - | - | - |
Debt repayment | - | - | -77.09 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -25.58 Million | - | - | - |
Accounts receivables | - | - | 258.24 Million | - | - | - |
Accounts payables | - | - | 3.61 Billion | - | - | - |
Inventory | - | - | -302.67 Million | - | - | - |
Other working capital | - | - | 4.15 Billion | - | - | - |
Cash at beginning of period | - | - | 3 Billion | 3.63 Billion | 9.91 Billion | 3 Billion |
Cash at end of period | - | - | 3.18 Billion | 3.66 Billion | 3.63 Billion | -5.89 Billion |
Capital Expenditure | - | - | -21.22 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 178.66 Million | 33.33 Million | -6.28 Billion | -8.9 Billion |
Free Cash Flow | - | - | 129.71 Million | 33.33 Million | -6.28 Billion | -5.89 Billion |
NERV
GBIO
GPTHEALTH
REVB
KOCMT
LOVABLE